ClassID:

20298

A61K31/365 - page 5 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones

Recent Application in this class:
#1201
20130005666
2013-01-03

Reporter system for high throughput screening of compounds and uses thereof

#1202
20120329868
2012-12-27

Paraconic acids as pigmentation activators

#1203
20120328661
2012-12-27

Coumarin compounds as receptor modulators with therapeutic utility

#1204
20120328602
2012-12-27

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS

#1205
20120328593
2012-12-27

Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites

#1206
20120321684
2012-12-20

Color Cosmetic

#1207
20120316164
2012-12-13

METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELLS

#1208
20120316106
2012-12-13

SYNERGISTIC ANTIBIOTIC COMBINATIONS AND DERIVATIVES

#1209
20120315332
2012-12-13

PHARMACEUTICAL COMPOSITION INCLUDING SUNFLOWER EXTRACT, PREPARATIVE METHOD AND USE THEREOF

#1210
20120309818
2012-12-06

CHRONIC INFLAMMATION AND TRANSPLANTATION

#1211
20120309693
2012-12-06

Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation

#1212
20120295933
2012-11-22

TREATMENT OF COPD, GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES AND OTHER GASTROINTESTINAL CONDITIONS AND DISORDERS AMELIORATED BY PROPER HISTAMINE MANAGEMENT USING A COMBINATION OF HISTIDINE DECARBOXYLASE INHIBATORS, LRA DRUGS, ANTI-H1 AND/OR ANTI-H2 DRUGS

#1213
20120294941
2012-11-22

Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process

#1214
20120289557
2012-11-15

Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning

#1215
20120277179
2012-11-01

Edible energy composition

#1216
20120270860
2012-10-25

METHODS FOR TREATING OR PREVENTING ALCOHOL-RELATED DISORDERS OR CRAVING-RELATED DISORDERS

#1217
20120263677
2012-10-18

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

#1218
20120258956
2012-10-11

USE OF A SPIROLIDE, ANALOGUES AND DERIVATIVES FOR TREATING AND/OR PREVENTING PATHOLOGICAL CONDITIONS LINKED TO THE TAU AND BETA-AMYLOID PROTEINS

#1219
20120255502
2012-10-11

PACKAGE AND METHOD OF MARKETING

#1220
20120252905
2012-10-04

Drug delivery from rapid gelling polymer composition

#1221
20120245116
2012-09-27

Inhibiting GS-FDH to Modulate No Bioactivity

#1222
20120237601
2012-09-20

Pharmaceutical Compositions Comprising Mycophenolic Acid or Mycophenolate Salt

#1223
20120237511
2012-09-20

FGFR1 extracellular domain combination therapies for lung cancer

#1224
20120231050
2012-09-13

Synthetic lactone formulations and method of use

#1225
20120225936
2012-09-06

Method for producing triptolide

#1226
20120225934
2012-09-06

Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof

#1227
20120225889
2012-09-06

USE OF MACROCYCLIC LACTONE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#1228
20120220619
2012-08-30

Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease

#1229
20120213841
2012-08-23

Ophthalmic drug delivery system and method

#1230
20120208875
2012-08-16

Method for inhibiting blood vessel stenosis

#1231
20120208850
2012-08-16

Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid

#1232
20120208807
2012-08-16

TOFA analogs useful in treating dermatological disorders or conditions

#1233
20120208778
2012-08-16

Avermectins and milbemycins for the treatment, prevention or amelioration of flavivirus infections

#1234
20120202849
2012-08-09

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT/PROPHYLAXIS OF NON-ALCOHOLIC FATTY LIVER DISEASE

#1235
20120201884
2012-08-09

Extracts, fractions and compositions comprising acetogenins and their applications

#1236
20120201818
2012-08-09

TREATMENT OF MULTIPLE SCLEROSIS

#1237
20120195951
2012-08-02

Therapeutic Inhibitor of Vascular Smooth Muscle Cells

#1238
20120189721
2012-07-26

Methods and compositions for heavy metal detoxification

#1239
20120189720
2012-07-26

Method for treatment of diarrhea-predominant irritable bowel syndrome

#1240
20120184608
2012-07-19

N alkylcarbonyl amino lactone compounds and their use

#1241
20120165553
2012-06-28

IMMUNOSTIMULANT

#1242
20120165383
2012-06-28

INFLAMMATORY EYE DISEASE

#1243
20120164221
2012-06-28

COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT

#1244
20120164120
2012-06-28

NOVEL MONASCUSPURPURONES, PREPARATION PROCESS THEREOF, AND USES OF THE MONASCUSPURPURONES

#1245
20120157445
2012-06-21

Methods for improving cognitive function

#1246
20120157420
2012-06-21

TREATMENT AND PREVENTION OF SECONDARY INJURY AFTER TRAUMA OR DAMAGE TO THE CENTRAL NERVOUS SYSTEM

#1247
20120156314
2012-06-21

11 beta, 13-DIHYDROHELENALIN DERIVATIVES AND USES THEREOF AS BOMBESIN RECEPTOR SUBTYPE 3 AGNOISTS

#1248
20120149655
2012-06-14

Method of treating neurogenic overactive bladder in a mammal or method of treating non-psychological stress-related bladder dysfunction in a female mammal by administering at least on jasmonate

#1249
20120136338
2012-05-31

IMMUNOLOGIC COMPOUNDS FOR PREVENTION, PROTECTION, PROPHYLAXIS OR TREATMENT OF IMMUNOLOGICAL DISORDERS, INFECTIONS AND CANCER

#1250
20120135925
2012-05-31

Covalent inhibition of bacterial quorum sensing

#1251
20120135113
2012-05-31

Edible energy composition

#1252
20120134963
2012-05-31

Compositions and methods for enhancing virus efficacy

#1253
20120116051
2012-05-10

Polymer conjugate of bioactive substance having hydroxy group

#1254
20120114670
2012-05-10

METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS

#1255
20120114566
2012-05-10

Lipoxin analogs and methods for the treatment of periodontal disease

#1256
20120100175
2012-04-26

Antrocin containing pharmaceutical compositions for inhibiting cancer cells

#1257
20120093856
2012-04-19

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

#1258
20120093800
2012-04-19

Plant extract comprising statins and preparation techniques and uses thereof

#1259
20120077872
2012-03-29

PRESERVATIVE-FREE PHARMACEUTICAL TETRAHYDROLIPSTATIN COMPOSITIONS

#1260
20120071549
2012-03-22

Anti-inflammatory composition containing macrolactin A and a derivative thereof as active ingredients

#1261
20120071548
2012-03-22

Therapeutic compositions

#1262
20120071484
2012-03-22

Topical parasiticide composition

#1263
20120070506
2012-03-22

Animal Treatment

#1264
20120070473
2012-03-22

Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions

#1265
20120065256
2012-03-15

MILBEMYCIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH

#1266
20120064160
2012-03-15

Fibrate-statin Combinations with Reduced Fed-fasted Effects

#1267
20120058965
2012-03-08

Methods and systems for modulating hormones and related methods, agents and compositions

#1268
20120052117
2012-03-01

Soft capsule of butylphthalide and a process for preparing the same

#1269
20120052108
2012-03-01

Macrocyclic lactone drug delivery system

#1270
20120046296
2012-02-23

Palatable ductile chewable veterinary composition

#1271
20120046242
2012-02-23

MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY

#1272
20120045523
2012-02-23

COMBINATION OF A TLR3 LIGAND AND A CHEMOTHERAPY AGENT WHICH ACTS ON THE INTRINSIC "APOPTOSIS" PATHWAY IN THE TREATMENT OF CANCER

#1273
20120045519
2012-02-23

Use of deoxyelephantopin (DET) and analogues thereof for treatment of melanoma

#1274
20120041397
2012-02-16

METHOD OF TREATMENT OF PREMALIGNANT AND MALIGNANT SKIN LESIONS WITH CYTOTOXIC AGENTS

#1275
20120041167
2012-02-16

POLY(GLUTAMIC ACID)-DRUG CONJUGATE WITH AN AMINO ACID AS A LINKER

#1276
20120029070
2012-02-02

Burdock fruit extract containing arctigenin at high content and process for producing same

#1277
20120020970
2012-01-26

Method of treating lupus nephritis

#1278
20120015923
2012-01-19

USE OF ANDROGRAPHOLIDE COMPOUNDS FOR TREATING INFLAMMATION AND AIRWAY DISORDERS

#1279
20120010278
2012-01-12

Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections

#1280
20120010277
2012-01-12

AVERMECTIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH

#1281
20120010159
2012-01-12

COMBINATION THERAPIES WITH COX-2 INHIBITORS AND TREPROSTINIL

#1282
20120003250
2012-01-05

Pharmaceutical composition with immunomodulating function

#1283
20110319485
2011-12-29

Composition Having Anti-Helicobacter Pylori Activity And Its Application To Inhibit Helicobacter Pylori

#1284
20110301231
2011-12-08

Lipase inhibiting composition

#1285
20110301154
2011-12-08

SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY

#1286
20110300247
2011-12-08

Flaxseed lignan complex and its use thereof

#1287
20110300221
2011-12-08

Therapeutic Inhibitor of Vascular Smooth Muscle Cells

#1288
20110288167
2011-11-24

Butylphthalide intravenous emulsion and application thereof

#1289
20110288022
2011-11-24

TREATMENT OF DEPRESSIVE DISORDERS

#1290
20110281942
2011-11-17

Tautomycetin and tautomycetin analog biosynthesis

#1291
20110281920
2011-11-17

INJECTABLE PARASITICIDAL FORMULATIONS OF LEVAMISOLE AND MACROCYCLIC LACTONES

#1292
20110281916
2011-11-17

Migrastatin analogs and uses thereof

#1293
20110281902
2011-11-17

COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-AAG

#1294
20110280951
2011-11-17

Composition from Sphaeranthus indicus and Garcinia mangostana for the control of metabolic syndrome

#1295
20110280904
2011-11-17

Generation of virus-like particles and use as panfilovirus vaccine

#1296
20110275706
2011-11-10

Pharmaceutical Compositions Containing Lipase Inhibitors

#1297
20110269755
2011-11-03

COMPOSITIONS AND METHODS FOR TREATING VASCULAR, AUTOIMMUNE, AND INFLAMMATORY DISEASES

#1298
20110268825
2011-11-03

Compositions that include anthocyanidins and methods of use

#1299
20110263653
2011-10-27

Migrastatin analog compositions and uses thereof

#1300
20110263554
2011-10-27

Screen for inhibitors of filovirus and uses therefor

#1301
20110251144
2011-10-13

MOLECULAR MODULATORS OF THE WNT/BETA-CATENIN PATHWAY

#1302
20110245307
2011-10-06

Methods for Alzheimer's Disease Treatment and Cognitive Enhancement

#1303
20110245191
2011-10-06

Parasiticidal compositions comprising multiple active agents, methods and uses thereof

#1304
20110245149
2011-10-06

Methods to prevent and treat diseases

#1305
20110244043
2011-10-06

Controlled releasing composition

#1306
20110243917
2011-10-06

Composition for the prevention and treatment of absence seizures comprising PKC agonist as an effective ingredient

#1307
20110237497
2011-09-29

COMPOSITIONS OF A V-ATPASE INHIBITOR IN COMBINATION WITH A GLUCOCORTICOID RECEPTOR LIGAND AND METHODS OF USE

#1308
20110223249
2011-09-15

Extended release compositions comprising mycophenolate sodium and processes thereof

#1309
20110218143
2011-09-08

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

#1310
20110217335
2011-09-08

Synthesis of resorcylic acid lactones useful as therapeutic agents

#1311
20110212860
2011-09-01

Modulation of bacterial quorum sensing with synthetic ligands

#1312
20110196028
2011-08-11

PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS

#1313
20110190388
2011-08-04

Ursolic acid derivative and pharmaceutical composition thereof

#1314
20110190338
2011-08-04

Compounds and compositions useful in the treatment of malaria

#1315
20110178171
2011-07-21

COMPOUNDS FOR CANCER THERAPY

#1316
20110178050
2011-07-21

USE OF CYCLOLIGNANS FOR THE TREATMENT OF A HYPERACTIVE IMMUNE SYSTEM

#1317
20110160218
2011-06-30

Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles

#1318
20110158983
2011-06-30

COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES

#1319
20110152312
2011-06-23

Antiparisitic dihydroazole compounds and compositions comprising same

#1320
20110144046
2011-06-16

ANTHELMINTIC COMPOSITIONS

#1321
20110142953
2011-06-16

Combinations of immunosuppressive agents for the treatment or prevention of graft rejections

#1322
20110136852
2011-06-09

Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease

#1323
20110130390
2011-06-02

Use of COX-2 Inhibitors for the Treatment of Schizophrenia, Delusional Disorders, Affective Disorders, Autism or Tic Disorders

#1324
20110125090
2011-05-26

OPHTHALMIC DRUG DELIVERY SYSTEM AND METHOD

#1325
20110123562
2011-05-26

ANTI-CANCER ACTIVE SUBSTANCE FROM ANTRODIA CAMPHORATA, METHOD FOR PREPARING THE SAME AND USE THEREOF

#1326
20110123470
2011-05-26

NATURAL BIOACTIVE COMPOUNDS

#1327
20110118347
2011-05-19

TREATMENT Of RINGWORM

#1328
20110092522
2011-04-21

Wound and skin care compositions

#1329
20110091559
2011-04-21

COMPOSITIONS COMPRISING ADJUVANT, MACROLIDE AND PROTEINACEOUS ANTIGEN AND METHODS OF USE THEREOF

#1330
20110077258
2011-03-31

Treatment of malaria

#1331
20110076293
2011-03-31

TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION

#1332
20110064677
2011-03-17

Lipoxin analogs and methods for the treatment of periodontal disease

#1333
20110053240
2011-03-03

DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORS

#1334
20110052740
2011-03-03

Skin Circulation-Improving Agent And Skin Temperature-Elevating Agent

#1335
20110045102
2011-02-24

Cancer chemotherapy compositions comprising PI3K pathway modulators and triptolide

#1336
20110045085
2011-02-24

PROCESS FOR OBTAINING POWDER COMPOSITIONS OF ORLISTAT

#1337
20110039794
2011-02-17

Long Acting Injectable Formulations

#1338
20110039790
2011-02-17

Enhanced ocular neuroprotection and neurostimulation

#1339
20110034708
2011-02-10

Pharmaceutical composition effective against biofilms

#1340
20110034518
2011-02-10

Pharmaceutical composition

#1341
20110033565
2011-02-10

Protective compositions for dermal papilla cells

#1342
20110033457
2011-02-10

COMBINATION OF EPOTHILONE ANALOGS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#1343
20110027368
2011-02-03

Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same

#1344
20110021508
2011-01-27

Methods for Alzheimer's Disease treatment and cognitive enhancement

#1345
20110009479
2011-01-13

Stimulating Neuronal Growth Using Brevetoxins

#1346
20110009475
2011-01-13

METHODS FOR TREATING STRESS INDUCED EMOTIONAL DISORDERS

#1347
20110008426
2011-01-13

MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING MYCOPHENOLATE AND PROCESSES THEREOF

#1348
20110008338
2011-01-13

Treatment of Autoimmune Diseases

#1349
20110008337
2011-01-13

Treatment of vasculitis

#1350
20110008336
2011-01-13

Treatment of Autoimmune Diseases

#1351
20110008269
2011-01-13

Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis

#1352
20110008250
2011-01-13

Treatment of Autoimmune Diseases

#1353
20100317642
2010-12-16

PHARMACEUTICAL COMPOSITION OF ORLISTAT

#1354
20100311711
2010-12-09

Inhibitors of NAAA and Methods Thereof

#1355
20100305204
2010-12-02

COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS

#1356
20100305150
2010-12-02

TUBEROUS SCLEROSIS TREATMENT

#1357
20100303937
2010-12-02

NOVEL COMPOSITION TO INCREASE TESTOSTERONE LEVELS

#1358
20100303792
2010-12-02

PROTEIN SYNTHESIS REQUIRED FOR LONG-TERM MEMORY IS INDUCED BY PKC ACTIVATION ON DAYS PRECEDING ASSOCIATIVE LEARNING

#1359
20100298294
2010-11-25

Ketone bodies and ketone body esters as blood lipid lowering agents

#1360
20100298248
2010-11-25

Biologically active macrolides, compositions, and uses thereof

#1361
20100292218
2010-11-18

Treatment of neurofibromatosis with radicicol and its derivatives

#1362
20100292177
2010-11-18

Methods of treatment using combination therapy

#1363
20100290983
2010-11-18

Compositions and methods for drug delivery

#1364
20100286222
2010-11-11

USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS

#1365
20100280129
2010-11-04

Method of treating pain caused by inflammation

#1366
20100280126
2010-11-04

Method of inhibiting inflammatory pain

#1367
20100280017
2010-11-04

Combination of selected analgesics and COX-II inhibitors

#1368
20100278874
2010-11-04

Reagents and methods for cancer treatment and prevention

#1369
20100266628
2010-10-21

Macrocyclic lactone combination compositions, vaccines and methods for producing same

#1370
20100256227
2010-10-07

Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor

#1371
20100249222
2010-09-30

Methods of treating skin with aromatic skin-active ingredients

#1372
20100227923
2010-09-09

PREVENTIVE/REMEDY FOR URINARY CALCULOSIS

#1373
20100227918
2010-09-09

STREPTOMYCES-DERIVED ANTIMICROBIAL COMPOUND AND METHOD OF USING SAME AGAINST ANTIBIOTIC-RESISTANT BACTERIA

#1374
20100227797
2010-09-09

USE OF CYCLOLIGNANS FOR THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES

#1375
20100221326
2010-09-02

PHARMACEUTICAL COMPOSITIONS FOR ORAL USE FOR TREATING PATIENTS AFFECTED BY OBESITY

#1376
20100216728
2010-08-26

NEW USE OF SPECIFIC CYKLOLIGNANS

#1377
20100210717
2010-08-19

PHARMACEUTICAL COMPOSITIONS COMPRISING MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

#1378
20100209464
2010-08-19

Color cosmetic

#1379
20100203032
2010-08-12

Orlistat compositions

#1380
20100197624
2010-08-05

Anthelmintic combination

#1381
20100196464
2010-08-05

ORLISTAT PHARMACEUTICAL FORMULATIONS

#1382
20100184804
2010-07-22

METHODS FOR THE PREVENTION OR TREATMENT OF BACTERIAL AND FUNGAL INFECTIONS

#1383
20100184725
2010-07-22

Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin

#1384
20100183686
2010-07-22

Method to maintain the efficacy of orlistat

#1385
20100179091
2010-07-15

Treatment of Conditions Related to Shock

#1386
20100178355
2010-07-15

METHOD FOR IN SITU SOLIDIFICATION OF BLOOD-POLYMER COMPOSITIONS FOR REGENERATIVE MEDICINE AND CARTILAGE REPAIR APPLICATIONS

#1387
20100173982
2010-07-08

Method for the asymmetric synthesis of beta-lactone compounds

#1388
20100173876
2010-07-08

OIL-BASED NSAID COMPOSITIONS AND METHODS FOR MAKING AND USING SAME

#1389
20100173872
2010-07-08

Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin

#1390
20100168219
2010-07-01

Chronic inflammation and transplantation

#1391
20100168160
2010-07-01

Genipin derivatives and uses thereof

#1392
20100160423
2010-06-24

Small molecule antagonists of bacterial quorum-sensing receptors

#1393
20100144853
2010-06-10

NOVEL COMBINED ADMINISTRATION

#1394
20100143449
2010-06-10

ANALGESIC COMPOSITION OF TOPICALLY APPLIED NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND OPIOIDS

#1395
20100143409
2010-06-10

Generation of virus-like particles and use as panfilovirus vaccines

#1396
20100143296
2010-06-10

PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II

#1397
20100143257
2010-06-10

Prevention of Cancers by Immunization

#1398
20100135992
2010-06-03

Prolongation of Survival of an Allograft by Inhibiting Complement Activity

#1399
20100129432
2010-05-27

MICROORGANISM-KILLING COMBINATION

#1400
20100129418
2010-05-27

METHOD OF INDUCING NEGATIVE CHEMOTAXIS USING AN ELLAGITANNIN OR GALLOTANNIN

#1401
20100119519
2010-05-13

OPHTHALMIC DRUG DELIVERY SYSTEM AND METHOD

#1402
20100113581
2010-05-06

COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY

#1403
20100113580
2010-05-06

COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY

#1404
20100113481
2010-05-06

USE OF SERUM AMYLOID A GENE IN DIAGNOSIS AND TREATMENT OF GLAUCOMA AND IDENTIFICATION OF ANTI-GLAUCOMA AGENTS

#1405
20100099753
2010-04-22

Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivates and their uses

#1406
20100093652
2010-04-15

Preservative System for Emulsion-Based Therapeutic Topical Formulations

#1407
20100087497
2010-04-08

Benzimidazole anthelmintic compositions

#1408
20100086543
2010-04-08

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS

#1409
20100074852
2010-03-25

Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors

#1410
20100069484
2010-03-18

SIGMA(s)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION

#1411
20100069372
2010-03-18

COMPOSITIONS AND METHODS FOR MODULATING POLY(ADP-RIBOSE) POLYMERASE ACTIVITY

#1412
20100063153
2010-03-11

Anti-cholesterolemic compounds and methods of use

#1413
20100063137
2010-03-11

Cytotoxin Compound And Method of Isolation

#1414
20100063052
2010-03-11

USE OF SERUM AMYLOID A GENE IN DIAGNOSIS AND TREATMENT OF GLAUCOMA AND IDENTIFICATION OF ANTI-GLAUCOMA AGENTS

#1415
20100048688
2010-02-25

Dietary and pharmaceutical compositions containing carnosol and/or rosmanol and their uses

#1416
20100048545
2010-02-25

Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity

#1417
20100048518
2010-02-25

Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent

#1418
20100035903
2010-02-11

Pyrrolo[2,3-D]pyrimidine compounds

#1419
20100029744
2010-02-04

Methods for Alzheimer's disease treatment and cognitive enhancement

#1420
20100022639
2010-01-28

Methods of Inducing Weight Loss

#1421
20100015149
2010-01-21

Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases

#1422
20100015121
2010-01-21

Inhibiting GS-FDH to modulate no bioactivity

#1423
20100010082
2010-01-14

FORMULATIONS FOR TREATING EYE DISORDERS

#1424
20100010081
2010-01-14

Anti-tumor effect of dimeric phthalide compound

#1425
20100009921
2010-01-14

Pharmaceutical compositions and methods for peptide treatment

#1426
20100004234
2010-01-07

SPECIFIC KINASE INHIBITORS

#1427
20100004156
2010-01-07

Small Compounds That Correct Protein Misfolding and Uses Thereof

#1428
20090326248
2009-12-31

Use of specific cyklolignans

#1429
20090317453
2009-12-24

TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS

#1430
20090311382
2009-12-17

Edible energy composition

#1431
20090311201
2009-12-17

Lipoxin analogs and methods for the treatment of periodontal disease

#1432
20090306201
2009-12-10

SELECTIVE INHIBITORS FOR TRANSFERASES

#1433
20090297497
2009-12-03

Methods and compositions for treating nephrogenic diabetes and insipidus

#1434
20090291976
2009-11-26

Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors

#1435
20090281177
2009-11-12

Butylphthalide Intravenous Emulsion and Application Thereof

#1436
20090280112
2009-11-12

INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS

#1437
20090274675
2009-11-05

Migraine tonic

#1438
20090264517
2009-10-22

Milbemycin compounds and treatment of dermatological disorders in humans therewith

#1439
20090264516
2009-10-22

Milbemycin compounds and treatment of dermatological disorders in humans therewith

#1440
20090253781
2009-10-08

Therapeutic compositions

#1441
20090253675
2009-10-08

Pharmaceutical formulation

#1442
20090247626
2009-10-01

Method of treating dyslipidemia using naturally occurring diterpene

#1443
20090246232
2009-10-01

Pharmaceutical composition

#1444
20090239830
2009-09-24

Treatment of viral infections by modulation of host cell metabolic pathways

#1445
20090239791
2009-09-24

PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC SUBSTANCE WHICH INHIBITS IL-2 PRODUCTION

#1446
20090227795
2009-09-10

TARGET MOLECULES OF PLADIENOLIDES, COMPOUNDS BINDING TO SUCH TARGET MOLECULES, AND SCREENING METHOD THEREOF

#1447
20090226518
2009-09-10

(MONITORING ONLY) COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPELIPIDEMIA ONCE A DAY AT NIGHT

#1448
20090221527
2009-09-03

Tumor necrosis factor inhibitors

#1449
20090220624
2009-09-03

Compositions comprising apocynin, ginkgo and ginger and uses thereof

#1450
20090215708
2009-08-27

Treatment of Sexual Dysfunction with Proton Pump Agonists

#1451
20090214682
2009-08-27

Composition and methods for weight loss in a subject

#1452
20090203784
2009-08-13

Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors

#1453
20090203772
2009-08-13

Vaginal health products

#1454
20090203713
2009-08-13

Hedgehog pathway antagonists to treat disease

#1455
20090203641
2009-08-13

Antibiotic compositions and related screening methods

#1456
20090202663
2009-08-13

Pharmaceutical composition for the treatment of otomycosis

#1457
20090202662
2009-08-13

Treatment of erectile dysfunction and libido enhancement

#1458
20090197939
2009-08-06

METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS

#1459
20090197849
2009-08-06

TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS

#1460
20090192215
2009-07-30

Cytotoxin compounds and methods of isolation

#1461
20090192214
2009-07-30

DRUG DELIVERY FROM RAPID GELLING POLYMER COMPOSITION

#1462
20090181150
2009-07-16

Cholesterol lowering supplement and low cholesterol egg produced by using the same

#1463
20090171621
2009-07-02

Measuring the distance between devices

#1464
20090171103
2009-07-02

Triptolide derivatives for modulation of apoptosis and immunosuppression

#1465
20090170925
2009-07-02

Methods for prognosing the ability of a zearalenone analog compound to treat cancer

#1466
20090163591
2009-06-25

USE OF SUGAR PHOSPHATES, SUGAR PHOSPHATE ANALOGS, AMINO ACIDS AND/OR AMINO ACID ANALOGS FOR MODULATING THE GLUCOLYSIS-ENZYME COMPLEX, THE MALATE ASPARATE SHUTTLE AND/OR THE TRANSAMINASES

#1467
20090162313
2009-06-25

High-molecular weight conjugate of podophyllotoxins

#1468
20090162286
2009-06-25

Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions

#1469
20090156667
2009-06-18

METHOD OF TREATING ASTHMA, ALLERGIC RHINITIS, AND SKIN DISORDERS

#1470
20090156661
2009-06-18

Compositions and Methods for Treatment and Prevention of Metabolic Syndrome and its Associated Conditions with Combinations of Flavonoids, Liminoids and Tocotrienols

#1471
20090155382
2009-06-18

Methods and compositions for heavy metal detoxification

#1472
20090149531
2009-06-11

CHEMICAL COMPOSITION DERIVED FROM P-HYDROXYPHENYL PROPIONIC ACID FOR THE TREATMENT OF PSORIASIS

#1473
20090143473
2009-06-04

USE OF INHIBITORS OF THE CELLULAR NA+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS

#1474
20090143282
2009-06-04

ENHANCED RECOVERY FOLLOWING OCULAR SURGERY

#1475
20090137680
2009-05-28

NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHOD FOR TREATING BRAIN SWELLING

#1476
20090124684
2009-05-14

Stimulation Of CPT-1 As A Means To Reduce Weight

#1477
20090124662
2009-05-14

Migrastatin analogs in the treatment of cancer

#1478
20090118341
2009-05-07

Method for treatment of chronic neuropathic pain

#1479
20090118317
2009-05-07

Statin-carboxyalkylether combinations

#1480
20090117210
2009-05-07

extract

#1481
20090117209
2009-05-07

ANDROGRAPHIS PANICULATA EXTRACT

#1482
20090104270
2009-04-23

Film delivery system for tetrahydrolipstatin

#1483
20090099251
2009-04-16

DIETARY AND PHARMACEUTICAL COMPOSITIONS CONTAINING TRICYCLIC DITERPENES AND THEIR DERIVATIVES AND THEIR USES

#1484
20090088427
2009-04-02

Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors

#1485
20090087432
2009-04-02

TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES

#1486
20090082425
2009-03-26

COMPOUNDS FROM MYROTHECIUM SP. FOR INHIBITING THE GROWTH OF CANCER CELLS

#1487
20090082313
2009-03-26

Multikinase inhibitors for use in the treatment of cancer

#1488
20090082260
2009-03-26

COMBINATION OF AN IMMUNOSUPPRESSANT AND A PPAR GAMMA AGONIST FOR THE TREATMENT OF AN UNDESIRABLE IMMUNE RESPONSE

#1489
20090075962
2009-03-19

Growth stimulant compositions

#1490
20090075918
2009-03-19

Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectin and/or milbemycin

#1491
20090068277
2009-03-12

Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom

#1492
20090042911
2009-02-12

Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4

#1493
20090041667
2009-02-12

Treatment of Depressive Disorders

#1494
20090036514
2009-02-05

Therapeutic effects of Bryostatins, Bryologs, and other related substances on Ischemia/stroke-induced memory impairment and brain injury

#1495
20090036458
2009-02-05

ENDOPARASITICIDAL TOPICAL COMPOSITIONS

#1496
20090023805
2009-01-22

METHOD OF ADMINISTRATION

#1497
20090011013
2009-01-08

Tacrolimus Combination Products

#1498
20090005440
2009-01-01

Pharmaceutical composition and health food comprising extract of sp. PL3 or phellinsin A isolated from the same as an effective component for prevention and treatment of cardiovascular disease

#1499
20080317857
2008-12-25

V-Atpase Inhibitors of Use in the Treatment of Septic Shock

#1500
20080312319
2008-12-18

Modulation of bacterial quorum sensing with synthetic ligands